300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in United Kingdom (October 2023)

The most active venture capital funds investing in United Kingdom Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in United Kingdom Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
UK Innovation & Science Seed Fund
VC Fund
50 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Medical $246k–$10M
Parkwalk Advisors
VC Fund
40 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $860k–$33M
Oxford Technology Management
VC Fund
34 United Kingdom, United States Seed, Series A Biotechnology, Health Care, Software $25k–$7.4M
Scottish Investment Bank
VC Fund
34 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Information Technology $307k–$7.6M
Oxford Science Enterprises
VC Fund
34 United Kingdom, United States, The Netherlands Seed, Series A Biotechnology, Health Care, Software $1M–$34M
Scottish Enterprise
VC Fund
33 United Kingdom, United States, Japan Grant, Seed Biotechnology, Software, Health Care $92k–$4.1M
Oxford Capital
VC Fund
33 United Kingdom, United States, France Seed, Series A Software, Mobile, Health Care $1.6M–$13M
Catapult Ventures
VC Fund
27 United Kingdom, United States, Israel Seed, Series A Health Care, Biotechnology, Pharmaceutical $123k–$26M
Mercia Fund Managers
VC Fund
24 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $184k–$21M
Archangels
VC Fund
21 United Kingdom, United States Seed, Series A Software, Biotechnology, Health Care $123k–$7M
AlbionVC
VC Fund
20 United Kingdom, United States, France Series A, Seed Software, Health Care, Artificial Intelligence $1.8M–$13M
Deepbridge Capital
VC Fund
19 United Kingdom, Australia, Singapore Seed, Series A Health Care, Biotechnology, Medical $143k–$10M
Epidarex Capital
VC Fund
19 United Kingdom, United States, Germany Series A, Seed, Series B Biotechnology, Therapeutics, Health Care $536k–$38M
GM&C Life Sciences Fund
VC Fund
18 United Kingdom, Italy, Germany Seed, Series A Health Care, Biotechnology, Medical $61k–$903k
Newable Private Investing
VC Fund
18 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $184k–$3.8M
Development Bank of Wales
VC Fund
18 United Kingdom, Australia, United States Seed, Debt Financing Health Care, Software, Biotechnology $12k–$2.8M
IP Group
VC Fund
17 United Kingdom, United States, Australia Seed, Series A, Series B Health Care, Biotechnology, Therapeutics $369k–$61M
Kelvin Capital
VC Fund
17 United Kingdom, United States Seed, Series A Health Care, Biotechnology, Manufacturing $139k–$24M
TRICAPITAL
VC Fund
16 United Kingdom, France Seed, Series B Biotechnology, Software, Health Care $172k–$6.4M
Sofinnova Partners
VC Fund
15 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Cambridge Angels group
VC Fund
15 United Kingdom, United States, Estonia Seed, Series A Software, Health Care, Biotechnology $244k–$16M
Par Equity
VC Fund
15 United Kingdom, United States, Brazil Seed, Series A Software, Information Technology, Computer $244k–$7.9M
Future Planet Capital
VC Fund
14 United Kingdom, United States Convertible Note, Seed Biotechnology, Health Care, Software $614k–$4.4M
24 Haymarket
VC Fund
13 United Kingdom, United States Seed, Series A Health Care, Software, Information Technology $1.2M–$16M
Nesta Ventures
VC Fund
13 United Kingdom, United States Seed, Series A Biotechnology, Medical Device, Medical $922k–$26M
Cambridge Innovation Capital
VC Fund
12 United Kingdom, United States, Ireland Series B, Series A, Seed Biotechnology, Health Care, Therapeutics $614k–$61M
Northstar Ventures
VC Fund
12 United Kingdom, United States, Estonia Seed, Series A Software, E-Commerce, Internet $37k–$8.8M
Calculus Capital
VC Fund
12 United Kingdom, United States, Ireland Series A, Post-IPO Equity Biotechnology, Software, Health Care $2.9M–$9M
YFM Equity Partners
VC Fund
12 United Kingdom, United States, Belgium Private Equity, Series A Software, Information Technology, Biotechnology $922k–$9.8M
O2h Ventures
VC Fund
12 United Kingdom, Hungary Seed, Series A, Pre-Seed Biotechnology, Health Care, Pharmaceutical $614k–$6.1M
Wellcome Trust
VC Fund
12 United States, United Kingdom, Germany Grant, Series C Biotechnology, Health Care, Pharmaceutical $1.2M–$90M
Syncona Partners LLP
VC Fund
12 United Kingdom, United States, Switzerland Series A, Series B, Series C Biotechnology, Therapeutics, Medical $17M–$123M
Longwall Venture
VC Fund
11 United Kingdom, Germany, Philippines Seed, Series A Biotechnology, Medical Device, Health Care $283k–$16M
Wren Capital
VC Fund
11 United Kingdom Seed, Series A Biotechnology, Health Care, Software $1.5M–$19M
SR One
VC Fund
11 United States, United Kingdom, Canada Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.7M–$85M
Amadeus Capital Partners
VC Fund
11 United Kingdom, United States, Spain Seed, Series B, Series A Software, Artificial Intelligence, Machine Learning $800k–$43M
Selvedge Venture
VC Fund
10 United Kingdom Seed, Pre-Seed, Series A Health Care, Biotechnology, Life Science $1.1M–$2.5M
Hoxton Ventures
VC Fund
10 United Kingdom, United States, Canada Seed, Series A Artificial Intelligence, Software, Information Technology $1.5M–$25M
M Ventures
VC Fund
10 United States, Switzerland, United Kingdom Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.1M–$67M
Octopus Ventures
VC Fund
9 United Kingdom, United States, Germany Series A, Seed, Series B Software, Health Care, FinTech $1.2M–$45M
BACKED VC
VC Fund
9 United Kingdom, United States, The Netherlands Seed, Series A Software, Enterprise Software, Blockchain $1.8M–$54M
SyndicateRoom
VC Fund
9 United Kingdom, United States, India Seed, Equity Crowdfunding Health Care, Software, Medical $229k–$1.8M
Providence Investment Company Limited
VC Fund
9 United Kingdom Series B, Seed Biotechnology, Biopharma, Medical
Cambridge Capital Group
VC Fund
9 United Kingdom, United States Seed, Series A Software, Biotechnology, Artificial Intelligence $528k–$7.8M
Techstart Ventures
VC Fund
9 United Kingdom, Ireland Seed, Pre-Seed Software, Health Care, Information Technology $86k–$2.5M
Dementia Discovery Fund
VC Fund
9 United States, United Kingdom, Israel Seed, Series A Biotechnology, Health Care, Therapeutics $5M–$42M
Kindred Capital
VC Fund
9 United Kingdom, Israel, Germany Seed, Series A, Series B Software, Biotechnology, Information Technology $557k–$30M
Astellas Venture Management
VC Fund
8 United States, United Kingdom, Japan Series A, Series B Biotechnology, Health Care, Therapeutics $2.5M–$50M
MVM Life Science Partners
VC Fund
8 United States, United Kingdom, Germany Series B, Series A Biotechnology, Health Care, Medical $6.5M–$40M
Angels in MedCity
VC Fund
8 United Kingdom, United States Seed, Angel Health Care, Biotechnology, Medical $614k–$774k
Access all 50 VC funds in United Kingdom Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

UK Innovation & Science Seed Fund
VC Fund · Harwell, Oxfordshire, United Kingdom · 50 investments in United Kingdom Biotech startups, 13 in the past 12 months

UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 96
  • Round size: Seed $246k–$2.9M; Series A $2.7M–$10M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • Pencil Biosciences — Next Generation Genome Editing Tool
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 40 investments in United Kingdom Biotech startups, 12 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 211
  • Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Show all investments...

Oxford Technology Management
VC Fund · Oxford, Oxfordshire, United Kingdom · 34 investments in United Kingdom Biotech startups

Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 104
  • Round size: Seed $25k–$2M; Series A $737k–$7.4M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: May invest from a new fund soon — last raise in 2012

Portfolio highlights

  • OxCan — Enabling curative cancer treatment through early detection
  • Machine Discovery — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 34 investments in United Kingdom Biotech startups

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 195
  • Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Oxford Science Enterprises
VC Fund · Oxford, Oxfordshire, United Kingdom · 34 investments in United Kingdom Biotech startups, 15 in the past 12 months

Oxford Sciences Innovation is the world’s largest university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companiestaking on challenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 123
  • Round size: Seed $1M–$6.8M; Series A $3.7M–$34M
  • Lead/follow: 41% lead, 59% follow

Portfolio highlights

  • Navenio — Navenio is a software technology company that provides location-based services for indoor environments via mobile applications. Its solution provides an improvement on other indoor localization technologies, having the ability to locate people without the need for implementing, managing, or surveying any new building hardware such as beacons orwi-fi. Navenio’s intelligent workforce solution unlocks significant improvements in the efficiency and workflow of staff and teams through automation that is carefully driven from real-world best practice.The company was founded in 2015 and is headquartered in Oxford, England.
  • AlveoGene — Welcome to AlveoGene Transforming Rare Respiratory Disease Outcomes Using Inhaled Gene Therapy More information
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
Show all investments...

Scottish Enterprise
VC Fund · Glasgow, Glasgow City, United Kingdom · 33 investments in United Kingdom Biotech startups, 24 in the past 12 months

Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Grant, Seed
  • Geography: United Kingdom, United States, Japan

Investor stats

  • Total investments: 193
  • Round size: Seed $197k–$2.9M; Grant $92k–$4.1M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Pneumagen — Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilitiesin glycobiology.
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • Rapscallion Soda — Award Winning, Fresh Fruit, Low Calorie Soft Drinks, Handmade in Scotland. Fresh batches made weekly. Free UK Mainland Delivery. International Shipping. Ginga Ninja | Burnt Lemon | Dry Lime | Scottish Rhubarb Soda | Scottish Strawberry Soda | Cranachan Soda | Blueberry Soda Love soda. Hate hangovers. Drink local.
Show all investments...

Oxford Capital
VC Fund · Oxford, Oxfordshire, United Kingdom · 33 investments in United Kingdom Biotech startups

Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.

Show more...

Investment focus

  • Industry: Software, Mobile, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 133
  • Round size: Seed $1.6M–$3.6M; Series A $1.6M–$13M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
  • HelloSelf — The UK's Trusted Online Private Clinical Therapy Service
  • Legislate — Legislate is an easy-to-use contract management platform which provides a suite of customisable contracts for businesses and landlords.
Show all investments...

Catapult Ventures
VC Fund · Leicester, Leicester, United Kingdom · 27 investments in United Kingdom Biotech startups

The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Israel

Investor stats

  • Total investments: 96
  • Round size: Seed $123k–$985k; Series A $1.6M–$26M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
  • Urban Machine — Salvaging the past to build the future- Stealth Startup
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 24 investments in United Kingdom Biotech startups, 8 in the past 12 months

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 119
  • Round size: Seed $184k–$1.8M; Series A $1.2M–$21M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
  • Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Show all investments...

Archangels
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 21 investments in United Kingdom Biotech startups, 6 in the past 12 months

Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $123k–$2.7M; Series A $1.5M–$7M
  • Lead/follow: 54% lead, 46% follow

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • Cytomos — Cytomos develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
AlbionVC
VC Fund · London, England, United Kingdom · 20 investments in United Kingdom Biotech startups, 9 in the past 12 months

AlbionVC supports visionary founders with long-term capital and scale-up expertise, and manages c. $1 billion of venture funds, invested in 50+ companies. AlbionVC is the technology investment arm of Albion Capital Group LLP. The technology team invest from seed through to Series B in high growth companies, predominantly in the UK. The team has a focus on B2B software and technology enabled services. AlbionVC %

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Series A, Seed
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 119
  • Round size: Seed $1.8M–$13M; Series A $3.2M–$12M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
  • tem. — In a few simple steps we can manage your renewable energy needs forever.
  • Ramp Growth — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
Show all investments...

Deepbridge Capital
VC Fund · Chester, Cheshire, United Kingdom · 19 investments in United Kingdom Biotech startups

Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Australia, Singapore

Investor stats

  • Total investments: 77
  • Round size: Seed $143k–$2.1M; Series A $1.8M–$10M
  • Lead/follow: 78% lead, 22% follow
  • Last fund: Likely still investing — raised $1.2M in 2022

Portfolio highlights

  • Circada — Innovative Circadian lighting reconnects the body clock with nature
  • Microplate Dx — Microplate Dx is a developer of diagnostic technology aimed at significantly reducing fatalities caused by drug-resistant infections.Microplate Dx, an award-winning spinout company from the University of Strathclyde in Glasgow, focuses on creating innovative diagnostic solutions to combat the significant global health challenge of antimicrobialresistance. Their technology revolves around the ingenious concept of employing highly sensitive biosensor electrodes, enhanced with miniaturized hydrogel deposits containing various antibiotics tailored to the specific infection being detected. The primary mission of Microplate DX is to proactively prevent and manage the proliferation of antimicrobial resistance on a global scale.
  • GenoMe Diagnostics — GenoME Diagnostics - We are developing a blood test for an earlier and more accurate diagnosis of ovarian cancer.GenoME Diagnostics .
Show all investments...

Epidarex Capital
VC Fund · Bethesda, Maryland, United States · 19 investments in United Kingdom Biotech startups

Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 39
  • Round size: Seed $536k–$8M; Series A $2M–$24M; Series B $2.4M–$38M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Transine Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 18 investments in United Kingdom Biotech startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 32
  • Round size: Seed $61k–$903k
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Show all investments...

Newable Private Investing
VC Fund · London, England, United Kingdom · 18 investments in United Kingdom Biotech startups

Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

Development Bank of Wales
VC Fund · Cardiff, Cardiff, United Kingdom · 18 investments in United Kingdom Biotech startups, 11 in the past 12 months

Development Bank of Wales is formed in 2001 by the Welsh Assembly Government. Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Debt Financing
  • Geography: United Kingdom, Australia, United States

Investor stats

  • Total investments: 149
  • Round size: Seed $307k–$1.8M; Debt Financing $12k–$2.8M
  • Lead/follow: 58% lead, 42% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Stratigens — Talent intelligence software| external people analytics | Diversity, location planning and skills data to inform strategy | Data based decision making
  • 2B Enterprising — 2B Enterprising offers an enterprise education program for primary schools that aims to inspire next generation and foster an entrepreneurial mindset.
Show all investments...

IP Group
VC Fund · London, England, United Kingdom · 17 investments in United Kingdom Biotech startups, 9 in the past 12 months

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Australia

Investor stats

  • Total investments: 157
  • Round size: Seed $369k–$6.4M; Series A $1.8M–$17M; Series B $7.4M–$61M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AccelerComm — Our patented, market-leading IP solutions for 4G and 5G are configurable for quick, high-performance implementations across a wide range of applications.
  • Deep Render — Deep Render Ltd. is a spin-out from the Department of Computing at Imperial College London. We are a London based AI start-up that is developing the next generation of media compression algorithms. Our proprietary and patented technology is at the forefront of machine learning research. Furthermore, our Biological Image Compression results arestate-of-the-art, providing at least a 50% efficiency gain over the previous standards
  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
Show all investments...

Kelvin Capital
VC Fund · Glasgow, Glasgow City, United Kingdom · 17 investments in United Kingdom Biotech startups

We invest venture capital in to globally ambitious companies which have the potential to deliver a significant return to our investors

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Manufacturing
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $139k–$1.1M; Series A $1.6M–$24M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • novosound — Novosound is an award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
  • Snappy Shopper — Order your favourite products from your local convenience store, for delivery from as little as 30 minutes with Snappy Shopper. Your every day essentials are only a click away - order your grocery delivery online or through our app.
  • Sofant Technologies — Sofant is developing a low cost RF MEMS technology that solves power consumption and heat problems in high frequency phased array antenna systems.
Show all investments...

TRICAPITAL
VC Fund · Melrose, Scottish Borders, The, United Kingdom · 16 investments in United Kingdom Biotech startups

The TRICAPITAL Syndicate is a business angel cohort of entrepreneurs, CEOs and business leaders who have founded, funded and built companies

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series B
  • Geography: United Kingdom, France

Investor stats

  • Total investments: 47
  • Round size: Seed $246k–$1.2M; Series B $172k–$6.4M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • ŌGI Bio — Offering an affordable route to automating routine microbial culturing with a unique, modular, retrofittable device
  • Carcinotech — Carcinotech is a MedTech company manufacturing 3D printed mini tumours developed from patient-specific cancer stem cells, primary cells and established cell lines.
  • Heero Technologies — Heero Technologies, the leading independent energy platform for making net zero homes a reality
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 15 investments in United Kingdom Biotech startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Cambridge Angels group
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 15 investments in United Kingdom Biotech startups

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.Typical funding requirements thatthe Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 116
  • Round size: Seed $244k–$2.5M; Series A $983k–$16M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Molymem — Molymem enhances the performance of filtering membranes used in separation processes including desalination and the removal of industrial contaminants.
  • Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
Show all investments...

Par Equity
VC Fund · Edinburgh, Edinburgh, City of, United Kingdom · 15 investments in United Kingdom Biotech startups, 11 in the past 12 months

Founded in 2008, Par Equity is a venture capital firm that backs the most innovative, high growth technology companies in the North of the UK. Based in Edinburgh, Par invests across Northern England, Northern Ireland and Scotland.

Show more...

Investment focus

  • Industry: Software, Information Technology, Computer
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Brazil

Investor stats

  • Total investments: 163
  • Round size: Seed $244k–$4.7M; Series A $1.6M–$7.9M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Plotbox — Award winning Cemetery and Crematory management software that enables world class death care facility operations. Fully integrated software and true digital mapping solve long standing problems and accelerates business development. Various packages available.
  • Partful — Make sure customers get the right parts first time, every time with digital 3D parts catalogue software and digital work instructions.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
Show all investments...

Future Planet Capital
VC Fund · London, England, United Kingdom · 14 investments in United Kingdom Biotech startups

Brilliant Ideas. Brilliant People. Brilliant Minds.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Convertible Note, Seed
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 113
  • Round size: Seed $614k–$4.4M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Captura — Captura mission is globally scalable carbon capture to support a sustainable future for the climate.
  • Regent — We build all-electric, passenger-carrying, wing-in-ground-effect vehicles to service coastal routes with technology available today.
  • Queen of Raw — Queen of Raw is a global marketplace with AI-powered supply chain software to eliminate and monetize textile waste, tracking and analyzing data to keep unused raw materials out of landfills and turn pollution into profit. An integrated dashboard allows its customers to visualize savings to their bottom- and top-lines as well as to the environmentby the actions they take across the Queen of Raw platform. Queen of Raw has helped 400,000+ users save millions of dollars—and more than a billion gallons of water.Queen of Raw is powered by mmx (http://www.materiamx.com/).
Show all investments...

24 Haymarket
VC Fund · London, England, United Kingdom · 13 investments in United Kingdom Biotech startups, 6 in the past 12 months

24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 95
  • Round size: Seed $1.2M–$3.7M; Series A $1.5M–$16M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • myGwork — The global recruitment & networking hub for LGBTQ+ professionals. Find jobs in lesbian, gay, bisexual and transgender friendly organisations. Grow your LGBTQ+ professional network. Read the latest LGBTQ+ professional news.
  • Previsico — Previsico is a spinOut company from Loughborough University specialising in modelling flooding in real-time, using weather predictions to make street-level flood nowcasts and forecasts. The company's mission is to be the leading global provider of cutting-edge flood prediction that saves lives and livelihoods.Its FloodMap Live producesround the clock street-level flood risk predictions and analytics. Uniquely, these are continuously modelled and updated using a combination of different weather forecasts. This allows the company to map the likelihood of short and long-term surface water events in real-time to the street level.
  • Huq Industries — The leading monitoring platform for footfall, dwell, catchment and traffic flows valued by government, retail and real-estate. Used by 50+ councils!
Show all investments...

Nesta Ventures
VC Fund · London, England, United Kingdom · 13 investments in United Kingdom Biotech startups

We bring bold ideas to life to change the world for good.

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Medical
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 72
  • Round size: Seed $922k–$2.2M; Series A $1.5M–$26M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2014

Portfolio highlights

  • Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
  • Featurespace — Featurespace™ is the world leader in Enterprise Financial Crime prevention for fraud and Anti-Money Laundering. Featurespace invented Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, both of which are available through the ARIC™ platform, a real-time machine learning software that risk scores events in more than 180 countriesto prevent fraud and financial crime.ARIC™ Risk Hub uses advanced, explainable anomaly detection to enable financial institutions to automatically identify risk, catch new fraud attacks and identify suspicious activity in real-time. More than 30 major global financial institutions are using ARIC to protect their business and their customers. Publicly announced customers include HSBC, TSYS, Worldpay, NatWest, Contis, Danske Bank, ClearBank, Akbank and Permanent TSB.
  • Radio Physics Solutions — Download Lagu MP3 Gratis. Download Lagu Gratis Terbaru 2023, Situs Download Lagu Mp3 Gratis, Download Lagu dari YouTube, Gudang Lagu Indonesia, Barat Terbaik, Cepat dan Mudah.
Show all investments...

Cambridge Innovation Capital
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 12 investments in United Kingdom Biotech startups, 8 in the past 12 months

Cambridge Innovation Capital backs life sciences and technology companies with an affiliation to Cambridge, Europe’s capital for innovation. As a preferred investor for the University of Cambridge, they have unparalleled access to investment opportunities in the ecosystem.Since our inception in 2013, they have raised £275 million to invest indisruptive, deep-tech businesses in sectors including, but not limited to, artificial intelligence, the internet of things, quantum technologies, autonomous systems, therapeutics, medtech/diagnostics, digital health, and genomics/proteomics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Seed
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 81
  • Round size: Seed $614k–$13M; Series A $1.8M–$39M; Series B $6.5M–$61M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
  • Mosaic Therapeutics — Mosaic Therapeutics is reshaping the interface of computational and experimental medicine to power new medicines for patients.
  • Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Show all investments...

Northstar Ventures
VC Fund · Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom · 12 investments in United Kingdom Biotech startups

Northstar Ventures is a venture capital firm investing in innovative solutions to help solve the most pressing societal issues we have today.  Our ticket sizes range from £100k to £500k into early stage tech companies. We provide added value in leveraging our network of university partners, funders, non-executive directors and talent to supporteach investment.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Estonia

Investor stats

  • Total investments: 153
  • Round size: Seed $37k–$1.2M; Series A $276k–$8.8M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • MarraBio — MarraBio Ltd. is a spin out company from Newcastle University using engineered bacterial protein polymers to provide bioactivity to cells at the industrial scale in the cultivated meat sector and beyond.
  • Peek Home — Peek Home provides sketch plans, prices and planning advice for people who are puzzled by the process of creating their perfect home. All we need is your house number & postcode - no home visit needed.
Show all investments...

Calculus Capital
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups

At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Post-IPO Equity
  • Geography: United Kingdom, United States, Ireland

Investor stats

  • Total investments: 59
  • Round size: Series A $3.1M–$6.5M; Post-IPO Equity $2.9M–$9M
  • Lead/follow: 68% lead, 32% follow

Portfolio highlights

  • Wazoku — Wazoku - Where Innovation Works Wazoku
  • Arctic Shores — Unearth meaningful, job-relevant insights through our candidate assessments. A new type of behaviour based assessment that's powered by neuroscience.
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Show all investments...

YFM Equity Partners
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups, 12 in the past 12 months

YFM Equity Partners is an independent private equity business owned by its senior management and investment team. They invest up to £10 million of equity through offices in Leeds, London, Manchester, Birmingham and Sheffield.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Private Equity, Series A
  • Geography: United Kingdom, United States, Belgium

Investor stats

  • Total investments: 94
  • Round size: Series A $922k–$6.9M; Private Equity $2.5M–$9.8M
  • Lead/follow: 70% lead, 30% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
  • Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
  • GEEIQ — GEEIQ enables businesses of every shape and size to navigate and engage the metaverse. Our platform helps identify opportunities and create data-led virtual strategies in Web3, gaming and virtual environments.
Show all investments...

O2h Ventures
VC Fund · 12 investments in United Kingdom Biotech startups

Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United Kingdom, Hungary

Investor stats

  • Total investments: 23
  • Round size: Seed $614k–$3.2M; Pre-Seed $1.7M–$2.5M; Series A $1.8M–$6.1M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Wellcome Trust
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Grant, Series C
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 109
  • Round size: Grant $1.2M–$6.8M; Series C $10M–$90M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
  • Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Show all investments...

Syncona Partners LLP
VC Fund · London, England, United Kingdom · 12 investments in United Kingdom Biotech startups

Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United Kingdom, United States, Switzerland

Investor stats

  • Total investments: 37
  • Round size: Series A $17M–$110M; Series B $22M–$123M; Series C $40M–$80M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Beacon Therapeutics — Beacon Therapeutics is an ophthalmic gene therapy company that restores and improves vision and rare retinal diseases that result in blindness.
  • Mosaic Therapeutics — Mosaic Therapeutics is reshaping the interface of computational and experimental medicine to power new medicines for patients.
  • SwanBio Therapeutics — SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, genetically defined neurological conditions.
Show all investments...

Longwall Venture
VC Fund · Harwell, Oxfordshire, United Kingdom · 11 investments in United Kingdom Biotech startups

Longwall Ventures invests in innovative, UK based, early stage companies in the healthcare, science and engineering sectors

Show more...

Investment focus

  • Industry: Biotechnology, Medical Device, Health Care
  • Stage:Seed, Series A
  • Geography: United Kingdom, Germany, Philippines

Investor stats

  • Total investments: 39
  • Round size: Seed $283k–$5.3M; Series A $2.1M–$16M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: May invest from a new fund soon — raised $92M in 2017

Portfolio highlights

  • Wayland Additive — Wayland Additive Limited is a West-Yorkshire based company pushing the boundaries of electron beam 3D printing. Wayland’s goal is to develop, manufacture and sell metal Additive Manufacturing (“AM” – 3D printing) machines to industrial end-users such as major players in the aerospace and medical industries.
  • Caristo Diagnostics — Coronary Artery Inflammation causes heart attacks. We detect and measure coronary inflammation and plaque on CCTA with CaRi-Heart technology
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Wren Capital
VC Fund · London, England, United Kingdom · 11 investments in United Kingdom Biotech startups

Wren is an angel investor in science, engineering and software. They founded Wren in 2011 and have invested in 50 companies so far.Wren is well known in the early stage investment community and has co-invested with a wide range of both angel and institutional investors. From software and semiconductors to genome editing, and from medical devicesto satellites, they are interested in sectors where technical ingenuity and hard work can produce long term value. They look for people with a deep understanding of their markets. The founders they invest in are smart and they get things done.Wren typically invests £50,000 to £200,000 per funding round. Difficult problems take time to solve, so they are patient with their investments. Their aim is to get deals done and they take a pragmatic approach to doing so.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $1.5M–$3M; Series A $2.1M–$19M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
  • MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
  • Bastion Therapeutics — Bastion Therapeutics - Enhancing Tregs To Restore Balance In Inflammatory Disorders Treg cell therapy for inflammatory disorders and autoimmune diseases.
Show all investments...

SR One
VC Fund · Cambridge, Massachusetts, United States · 11 investments in United Kingdom Biotech startups, 8 in the past 12 months

SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 154
  • Round size: Series A $3.7M–$40M; Series B $15M–$85M; Series C $27M–$57M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • Avalyn Pharma — This does NOT display on the home page
  • Nimbus Therapeutics — Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company. Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinicaldevelopment. We are designing highly selective and potent medicines to disrupt known drivers of serious diseases, including metabolic disease, cancer and immune-inflammatory disorders.
Show all investments...

Amadeus Capital Partners
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 11 investments in United Kingdom Biotech startups, 7 in the past 12 months

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Machine Learning
  • Stage:Seed, Series B, Series A
  • Geography: United Kingdom, United States, Spain

Investor stats

  • Total investments: 197
  • Round size: Seed $800k–$7.5M; Series A $2M–$25M; Series B $6M–$43M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — raised $86M in 2023

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
  • Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
Show all investments...

Selvedge Venture
VC Fund · London, England, United Kingdom · 10 investments in United Kingdom Biotech startups

Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Life Science
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom

Investor stats

  • Total investments: 11
  • Round size: Seed $1.4M–$1.5M; Pre-Seed $1.1M–$2.5M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • Exogene — Exogene is a biotechnology company accelerating the discovery of T-cell-receptor(TCR)-based cancer immunotherapies for solid tumours by combining deep learning and high-throughput TCR-antigen screening. Exogene is building a computational platform to quickly and inexpensively identify new tumour targets shared across cancer patients, as well assafe and effective TCRs against these tumour targets for therapeutic application. Their mission is to develop better TCR-based immunotherapies, faster and at a fraction of the cost.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Show all investments...

Hoxton Ventures
VC Fund · London, England, United Kingdom · 10 investments in United Kingdom Biotech startups, 11 in the past 12 months

Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Canada

Investor stats

  • Total investments: 101
  • Round size: Seed $1.5M–$8.6M; Series A $4.2M–$25M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $215M in 2022

Portfolio highlights

  • Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
  • Graphext — Graphext is a no-code platform for business intelligence helping you to build powerful data science projects.
  • DRUID — DRUID is an AI platform that allows companies to automate processes by designing and deploying UiPath RPA integrated chatbot virtual assistants.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 10 investments in United Kingdom Biotech startups, 17 in the past 12 months

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 119
  • Round size: Seed $2.1M–$18M; Series A $6M–$42M; Series B $9.5M–$67M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • CellFE — CellFE is a company developing a microfluidics based device to deliver gene-editing molecules. CellFE developed microfluidic device and process that can efficiently deliver gene-editing molecules into the human cells.
  • BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
  • Lightcast Discovery — Flexible control over droplet number, occupancy, location and movement. Enabling efficient, multi-step workflows with unprecedented flexibility.
Show all investments...

Octopus Ventures
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Biotech startups, 36 in the past 12 months

We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Series A, Seed, Series B
  • Geography: United Kingdom, United States, Germany

Investor stats

  • Total investments: 273
  • Round size: Seed $1.2M–$6.1M; Series A $2.5M–$15M; Series B $5.9M–$45M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Automata — Automata is a deep-tech company that creates products that empower people to automate physical work. The company's product, Eva, is a lightweight and affordable robot arm built for professionals in a production line, in a lab, a home workshop or even in a classroom. People don't need to be technical experts to communicate with robots. Theweb-based software platform can be programmed by anyone, anywhere, any time, from any device, making it easy to reconfigure for a wide range of different tasks.Automata was founded on 2015 and is headquartered in London, England.
  • Awell Health — Ollie is a vast library of over 100 interface blocks with complete Webflow CMS integration. Build beautiful websites in less time than ever.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
BACKED VC
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Biotech startups

BACKED is the human-centric venture capital fund. We invest in exceptional founders at Seed in Europe. Welcome to Different.

Show more...

Investment focus

  • Industry: Software, Enterprise Software, Blockchain
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, The Netherlands

Investor stats

  • Total investments: 84
  • Round size: Seed $1.8M–$6M; Series A $4.2M–$54M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Hoxton Farms — Based in London, UK, Hoxton Farms is growing real animal fat – without animals. The company combines cell biology and mathematical modelling to produce cultivated fat as an ingredient for the meat alternatives industry.
  • Borderless — Borderless is a workforce migration platform.It offers automation solutions that focuses on all aspects of hiring and onboarding of foreign workers, including recruitment, immigration, relocation, and compliance.
  • Flow Engineering — Requirements management, made collaborative
Show all investments...

SyndicateRoom
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in United Kingdom Biotech startups, 6 in the past 12 months

SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical
  • Stage:Seed, Equity Crowdfunding
  • Geography: United Kingdom, United States, India

Investor stats

  • Total investments: 109
  • Round size: Seed $240k–$1.8M; Equity Crowdfunding $229k–$1.5M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Connectd — Online platform underpinned by smart matching technology directly connecting the UK’s leading Founders, Investors & NAMs.
  • Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
  • Pencil Biosciences — Next Generation Genome Editing Tool
Show all investments...

Providence Investment Company Limited
VC Fund · Germany, Georgia, United States · 9 investments in United Kingdom Biotech startups

Providence Investment Company

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Medical
  • Stage:Series B, Seed
  • Geography: United Kingdom

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
  • DefiniGEN — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
  • CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
Show all investments...

Cambridge Capital Group
VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in United Kingdom Biotech startups

Cambridge Capital Group (CCG) is a leading business angel group of 70+ investors who have been investing in hi-tech businesses for more than a decade. CCG was formed in the Autumn of 2000 and has been backing tech start-ups in the region ever since. Their members have invested several millions of pounds into more than 30 live portfolio companies inthe Cambridge technology cluster. Membership is an application process, normally following introductions by existing members.Their partner networks are Anglia Capital Group and CCG International, both of which benefit from deal flow developed in Cambridge, Europe's leading hi-tech cluster.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 40
  • Round size: Seed $528k–$1.8M; Series A $1.2M–$7.8M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • Qualus — Bringing sustainable leather solutions to leather tanneries and brands. Qualus enables you to deliver environmentally friendly luxury leather production.
  • Cytochroma — Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.
  • Cambridge GaN Devices — Cambridge GaN Devices develops transistors designed to bring widespread adoption of GaN technology in consumer electronics.
Show all investments...

Techstart Ventures
VC Fund · Belfast, Belfast, United Kingdom · 9 investments in United Kingdom Biotech startups, 7 in the past 12 months

Techstart Ventures is a leading investor of seed capital across Scotland and Northern Ireland. they are a trusted partner to ambitious founders on their journey to success.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: United Kingdom, Ireland

Investor stats

  • Total investments: 121
  • Round size: Seed $154k–$2.5M; Pre-Seed $86k–$1.5M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Obbi Golf — Integrating Compliance, Safety and Quality across your Golf Club. Integrate greenkeepers, hospitality, pro shop and management.
  • loveelectric — loveelectric is on a mission to halve the cost of motoring
  • Desana — Seamlessly integrate existing assets into a global network of flexible workspaces and meeting rooms so staff can work from quality environments. Wherever.
Show all investments...

Dementia Discovery Fund
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Biotech startups

SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 36
  • Round size: Seed $5.5M–$15M; Series A $5M–$42M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
  • Violet Therapeutics — Violet Therapeutics is a healthcare company that operates in stealth mode.
Show all investments...

Kindred Capital
VC Fund · London, England, United Kingdom · 9 investments in United Kingdom Biotech startups

A new model for Venture Capital where every founder we back becomes a co-owner of the fund

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Israel, Germany

Investor stats

  • Total investments: 81
  • Round size: Seed $557k–$8.6M; Series A $7.4M–$30M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • m3ter — We enable software companies to intelligently deploy all usage-based scenarios whether they charge by subscription, consumption, or a hybrid pricing model.
  • Vitaance — Vitaance is a new insurtech start-up in the life insurance industry. We aim to improve people's quality of life through financial, emotional and physical wellbeing, by creating smart, fair and responsible insurance products enabled by technology. We want to democratize access to life insurance and to a healthier lifestyle.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Show all investments...

Astellas Venture Management
VC Fund · Menlo Park, California, United States · 8 investments in United Kingdom Biotech startups

Astellas Venture Management is a California-based financial organization that targets investments in the biotechnology sector.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Japan

Investor stats

  • Total investments: 58
  • Round size: Series A $2.5M–$45M; Series B $21M–$50M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — last raise in 2005

Portfolio highlights

  • DEM BioPharma — DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
  • Solu Therapeutics — Solu Therapeutics is a precision-medicine-focused company developing therapeutics to eliminate disease-driving cells.
  • Casma Therapeutics — Casma Therapeutics is a developer of a natural cellular process of autophagy to open new target areas for drug discovery and development. The company focuses on autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens as well as tries to arrest or reverse the progression of lysosomalstorage disorders, muscle disorders, inflammatory disorders and neurodegeneration, enabling physicians to address unmet medical needs.
Show all investments...

MVM Life Science Partners
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Biotech startups

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 61
  • Round size: Series A $6.5M–$36M; Series B $6.5M–$40M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
  • Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.
  • Neurolens — 2/3 of patients experience the symptoms of eye misalignment, but relief is in sight with Neurolens using the NMD2 and Neurolenses with Contoured Prism.
Show all investments...

Angels in MedCity
VC Fund · London, England, United Kingdom · 8 investments in United Kingdom Biotech startups

Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Angel
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $614k–$774k
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Atelerix — The Atelerix technology provides an innovative solution for storing and transporting cells and tissues at room temperature.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in United Kingdom Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists